Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $443.48MP/E –Yield –
Vireo Growth cash
Cash and short-term investments held at the end of each period.
Vireo Growth's cash was $88.80M at Sep 30, 2026. For fiscal 2025 it was $103.20M, up 12.7% from the year before. The highest annual figure on record is $103.20M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.20M | +12.7% |
| FY2024 | Dec 31, 2024 | $91.60M | +473.8% |
| FY2023 | Dec 31, 2023 | $15.96M | +5.4% |
| FY2022 | Dec 31, 2022 | $15.15M | -0.0% |
| FY2021 | Dec 31, 2021 | $15.16M | -44.1% |
| FY2020 | Dec 31, 2020 | $27.11M | +193.5% |
| FY2019 | Dec 31, 2019 | $9.23M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $88.80M | -25.1% |
| Q2 FY2026 | Jun 30, 2026 | $104.10M | -2.8% |
| Q1 FY2026 | Mar 31, 2026 | $123.40M | +43.2% |
| Q4 FY2025 | Dec 31, 2025 | $103.20M | +12.7% |
| Q3 FY2025 | Sep 30, 2025 | $118.51M | +1527.9% |
| Q2 FY2025 | Jun 30, 2025 | $107.10M | +853.8% |
| Q1 FY2025 | Mar 31, 2025 | $86.20M | +583.9% |
| Q4 FY2024 | Dec 31, 2024 | $91.60M | +473.8% |
| Q3 FY2024 | Sep 30, 2024 | $7.28M | -45.2% |
| Q2 FY2024 | Jun 30, 2024 | $11.23M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | $12.60M | +21.8% |
| Q4 FY2023 | Dec 31, 2023 | $15.96M | +5.4% |
| Q3 FY2023 | Sep 30, 2023 | $13.30M | -39.1% |
| Q2 FY2023 | Jun 30, 2023 | $11.35M | -33.1% |
| Q1 FY2023 | Mar 31, 2023 | $10.35M | +20.3% |
| Q4 FY2022 | Dec 31, 2022 | $15.15M | -0.0% |
| Q3 FY2022 | Sep 30, 2022 | $21.84M | +85.4% |
| Q2 FY2022 | Jun 30, 2022 | $16.97M | -18.5% |
| Q1 FY2022 | Mar 31, 2022 | $8.60M | -78.8% |
| Q4 FY2021 | Dec 31, 2021 | $15.16M | -44.1% |
| Q3 FY2021 | Sep 30, 2021 | $11.78M | -34.1% |
| Q2 FY2021 | Jun 30, 2021 | $20.83M | +184.5% |
| Q1 FY2021 | Mar 31, 2021 | $40.56M | +245.8% |
| Q4 FY2020 | Dec 31, 2020 | $27.11M | +193.5% |
| Q3 FY2020 | Sep 30, 2020 | $17.87M | – |
| Q2 FY2020 | Jun 30, 2020 | $7.32M | – |
| Q1 FY2020 | Mar 31, 2020 | $11.73M | – |
| Q4 FY2019 | Dec 31, 2019 | $9.23M | – |
See a number that looks wrong?